DEFINITIVE PROXY

Company

TENAX THERAPEUTICS, INC.

Filed

August 1, 2012

Period of Report

August 31, 2012

Accession Number

0001354488-12-003793

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →